| Mrs Kimberly Marie Dearing, MACCCSLP | |
|
300 Seville Rd, Hurricane, WV 25526-9206 | |
| (304) 757-6805 | |
| Not Available |
| Full Name | Mrs Kimberly Marie Dearing |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 300 Seville Rd, Hurricane, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023353232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 0523 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kimberly Marie Dearing, MACCCSLP 300 Seville Rd, Hurricane, WV 25526-9206 Ph: (304) 757-6805 | Mrs Kimberly Marie Dearing, MACCCSLP 300 Seville Rd, Hurricane, WV 25526-9206 Ph: (304) 757-6805 |
News Archive
Seegene, Inc., a leader in multi-pathogen diagnostic testing, today announced that it has been awarded patent in the U.S. and Europe for Annealing Control Primer (ACP), a new technology for amplifying a specific region of a gene with much higher specificity and reproducibility than conventional approaches.
Most adults would rather keep talk about colons behind the bathroom door.It's time to talk, says Kim Turgeon, MD, FACP, gastroenterologist in Internal Medicine at the University of Michigan Health System.
Using ultrasound to measure the height of a woman's uterus is a good way to predict whether or not she is at risk of having babies born prematurely if she becomes pregnant with twins after IVF, according to new research presented at the 24th annual meeting of the European Society of Human Reproduction and Embryology in Barcelona today (Wednesday).
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.
› Verified 4 days ago
Cassidy Brooke Carr, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 179 Station Pl, Hurricane, WV 25526 Phone: 304-760-6300 | |
Mrs. Shawna Lea Donahue, MA CCC-S Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 179 Station Place Way, Hurricane, WV 25526 Phone: 304-760-6300 Fax: 304-201-5123 | |
Mrs. Julie E Blake, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 179 Station Place Way, Hurricane, WV 25526 Phone: 304-760-6300 Fax: 304-201-5123 | |
Erica Burdette, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 179 Station Pl, Suite 100, Hurricane, WV 25526 Phone: 304-760-6300 Fax: 304-201-5123 | |
Mrs. Jennifer Cox Allman, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 590 Poplar Fork Rd, Hurricane, WV 25526 Phone: 304-757-7826 | |
Mrs. Deidre Ann Kondik, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4000 Out Look Dr, Hurricane, WV 25526 Phone: 330-338-8862 |